BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coustals N, Ménard ML, Cohen D. Aripiprazole in Children and Adolescents. J Child Adolesc Psychopharmacol 2021;31:4-32. [PMID: 32931315 DOI: 10.1089/cap.2020.0014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Nicol GE, Ivanov I. Getting to Precision Psychopharmacology in Child Psychiatry: The Value of Adverse Treatment Effects. J Child Adolesc Psychopharmacol 2021;31:1-3. [PMID: 33595415 DOI: 10.1089/cap.2021.29196.gni] [Reference Citation Analysis]
2 Sugimoto Y, Yamamura K, Takayama T, Fukuta Y, Aoki K, Mikami K, Tomoda A. Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance. BMC Psychiatry 2021;21:204. [PMID: 33888067 DOI: 10.1186/s12888-021-03201-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Parmar A, Hulme D, Hacking D, Shymko G, Dragovic M, Terina G, Waters F. Aripiprazole in young people with early psychosis: a systematic review and meta-analysis of weight gain. Australas Psychiatry 2022;:10398562211037334. [PMID: 35001673 DOI: 10.1177/10398562211037334] [Reference Citation Analysis]
4 Rafaniello C, Sullo MG, Carnovale C, Pozzi M, Stelitano B, Radice S, Bernardini R, Rossi F, Clementi E, Capuano A. We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database. Front Psychiatry 2020;11:550201. [PMID: 33343407 DOI: 10.3389/fpsyt.2020.550201] [Cited by in F6Publishing: 1] [Reference Citation Analysis]